All About Cases And Settlements Involving Invokana


Invokana is an SGLT2 inhibitor designed to block a specific protein that helps the body reabsorb glucose in the bloodstream. 

Sadly, many patients who are prescribed Invokana to treat their Type-II diabetes have experienced serious complications, often resulting fatal. Many lawsuits have been filed against the manufacturer. Invokana lawsuit update claims that the drug manufacturer didn’t warn the patients and physicians about the possible side effects. 



The legal papers plainly insist that if the drug manufacturer had prior and adequate warnings against Invokana and its side effects, the physicians would have informed the patients of the risks, if prescribed at all. 

Some of the most prominent cases involving Invokana are:

September 2015:
An Invokana lawsuit for $1 billion (general and special damages more than $500 million each) was filed on behalf of Canadians in Ontario. Under a request for class-action status, the manufacturers involve a woman who took prescribed Invokana for 8 months and suffered kidney failure. 

December 2015:
In another case, it is alleged that the plaintiff wasn’t aware of the serious side effects of Invokana. The patient took the medicine a year back and soon developed diabetic ketoacidosis. She claimed that complete warnings about the possible risks weren’t provided. 

December 2015:
FDA issued an Invokana safety alert just before Arthur Portnoff led an Invokana lawsuit. He had started taking the drug in November 2014, developed diabetic ketoacidosis and was hospitalized 3 months later. Portnoff argues that Janssen failed to conduct reliable studies about Invokana, withheld information and failed to provide proper warnings.

February 2016:
This lawsuit was filed by Charles Maddox, who suffered diabetic ketoacidosis, a serious and potentially life-threatening condition soon after he stopped taking the medicine. 

May 2016:
A report indicated that more plaintiffs have led Invokana lawsuits including Maria Puente and Carlos Puente v. Janssen Pharmaceuticals Inc. et al. The lawsuit claims that Maria took the medicine for a month and suffered serious health complications including diabetic ketoacidosis and kidney damage.

Thousands of lawsuits have been filed till date and several are pending. It is estimated that thousands of complaints are still on hold for legal actions. If you too are waiting for a settlement against the sufferings caused to you post the intake of Invokana, Call up at 1(855)973-4136 for an immediate action.

Comments

Post a Comment

Popular posts from this blog

Three main side effects of Invokana you should know

Image
Invokana is part of a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors which has seen a huge response in the treatment of adults with type 2 diabetes. Type 2 diabetes is a disease in which a person has high levels of sugar in his or her blood, when the pancreas fails to create enough of insulin and regulate blood sugar. Invokana is manufactured by Janssen Pharmaceuticals, Inc., (a division of Johnson & Johnson) is supposed to help patients achieve glycemic control.  Unfortunately, there have been reports which suggest otherwise. The patients with diabetic complications led patients developing kidney injury and kidney failure, diabetic ketoacidosis, and toe, foot, or leg amputations after taking the drug. The following are the main   side effects of invokana : The kidneys are a vital component in the workings of Invokana, but the drug can develop reduced kidney function or kidney failure. When this occurs, the kidneys are unable to ...
Read more

Invokana Settlements - What You Should Know

Image
Invokana was marketed as a Janssen’s product and with its easy dietary restrictions compared to the other similar drugs, this became one of the most well-liked medications for diabetes. Unfortunately, soon after it was released for public use, there were plenty of adverse reports submitted to the FDA and the victims claimed for  invokana settlements . In fact, in May 2015, the administration body warned about Invokana's potentially life-altering health effect diabetic ketoacidosis (which is the condition of having excess amount of ketones in the body) and how it is an needless risk associated with the drug. In September 2015, there was a revised FDA warning which highlighted about how the drug can increase the risk of bone fracture and have reduced bone mineral density. The patients taking Invokana are twice more likely to face the risk of leg or foot amputation than those thriving on other similar medication. The other complications associated with the drug are: hypotensi...
Read more